Verified Nov 2026
Other
·

Osaka, Osaka Prefecture
·
Since 1781
Takeda is a global biopharmaceutical company founded in 1781 and headquartered in Osaka, Japan. With 10,000–50,000 employees and revenues exceeding $10 billion, it ranks among the top 20 pharmaceutical companies worldwide. The company serves oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies markets, operating in over 50 countries. In July 2026, Takeda announced a collaboration with the Indonesian Government on plasma-derived therapies.
Takeda at a glance
Revenue
$10B+
Est. band
Employees
10,000-50,000
Founded
1781
Headquarters
Osaka, Osaka Prefecture
Import activity
78
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
78
Named foreign suppliers
20
Top origins
Italy · Germany · Netherlands · Spain

Shared foreign counterparties do not establish that these companies buy from Takeda.
What this tells a buyer
Takeda imported from at least six countries in recent years, with significant shipments from suppliers in Italy, Germany, Switzerland, and the Netherlands, indicating a diversified global supply chain for pharmaceutical ingredients and packaging.
The company operates across five core therapeutic areas including oncology and gastroenterology, with marketed brands such as Ninlaro, Entyvio, and Vyvanse, and maintains capabilities in vaccines and immunology.
As Japan's pharmaceutical company and in Asia, Takeda employs approximately 49,500 people globally and serves patients across the U.S., Japan, and Europe.
Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026
STABILITY SIGNALS
Established & active
245 years in operation (founded 1781).
78 US import shipments on record.
Overview
Takeda is a global biopharmaceutical company founded in 1781 and headquartered in Osaka, Japan. With 10,000–50,000 employees and revenues exceeding $10 billion, it ranks among the top 20 pharmaceutical companies worldwide. The company serves oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies markets, operating in over 50 countries. In July 2026, Takeda announced a collaboration with the Indonesian Government on plasma-derived therapies.
At a glance
Attribute | Detail |
|---|---|
Founded | 1781 |
Headquarters | Osaka, Osaka Prefecture |
Employees | 10,000-50,000 |
Revenue | $10B+ (estimated) |
What Takeda makes
The company operates across five core therapeutic areas including oncology and gastroenterology, with marketed brands such as Ninlaro, Entyvio, and Vyvanse, and maintains capabilities in vaccines and immunology.
Products and capabilities described on the company's own site include Steel, LED (source: takeda.com).
Trade and customs footprint
Takeda imported from at least six countries in recent years, with significant shipments from suppliers in Italy, Germany, Switzerland, and the Netherlands, indicating a diversified global supply chain for pharmaceutical ingredients and packaging. US customs bill-of-lading records list 78 inbound shipments across 20 foreign suppliers, with top origins including Italy · Germany · Netherlands · Spain.
Latest developments
2026-07-13 — Takeda and Indonesian Government Announce Plasma-Derived Therapies Collaboration (takeda.com)
2026-05-13 — Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results | Takeda Pharmaceuticals (takeda.com)
2026-01-21 — Takeda Expands at Innovation Park Lake County - LCP (lakecountypartners.com)
2026-01-08 — Takeda, Halozyme Global Collaboration on Vedolizumab (takeda.com)
2025-12-30 — XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab :: XOMA Royalty Corporation (XOMA) (xoma.com)
2025-10-21 — Takeda Announces Oncology Partnership with Innovent (takeda.com)
Facilities
Takeda is headquartered in Osaka, Osaka Prefecture. Public sources also reference these locations:
Linz, Austria — takeda.com
Company details
As Japan's pharmaceutical company and in Asia, Takeda employs approximately 49,500 people globally and serves patients across the U.S., Japan, and Europe. Takeda was founded in 1781, has an estimated 10,000-50,000 employees, and is headquartered in Osaka, Osaka Prefecture. On the LightSource stability read it is rated "Established & active": 245 years in operation (founded 1781). 78 US import shipments on record.
Frequently asked questions
What does Takeda do?
Takeda is a global biopharmaceutical company founded in 1781 and headquartered in Osaka, Japan. With 10,000–50,000 employees and revenues exceeding $10 billion, it ranks among the top 20 pharmaceutical companies worldwide. The company serves oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies markets, operating in over 50 countries. In July 2026, Takeda announced a collaboration with the Indonesian Government on plasma-derived therapies.
Where is Takeda headquartered?
Takeda is headquartered in Osaka, Osaka Prefecture.
When was Takeda founded?
Takeda was founded in 1781.
How big is Takeda?
Takeda has an estimated 10,000-50,000 employees, with revenue in the $10B+ range (estimated).
Does Takeda import from overseas suppliers?
US customs bill-of-lading records show 78 inbound shipments for Takeda, with top origins including Italy · Germany · Netherlands · Spain.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
